CAPI, MATILDE
 Distribuzione geografica
Continente #
NA - Nord America 1.148
EU - Europa 373
AS - Asia 179
AF - Africa 19
SA - Sud America 5
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.728
Nazione #
US - Stati Uniti d'America 1.135
IT - Italia 220
SG - Singapore 78
IN - India 44
SE - Svezia 42
CN - Cina 37
FI - Finlandia 20
RU - Federazione Russa 18
TG - Togo 18
IE - Irlanda 16
DE - Germania 14
CA - Canada 13
GB - Regno Unito 12
BG - Bulgaria 11
ID - Indonesia 10
UA - Ucraina 7
HK - Hong Kong 6
NL - Olanda 6
AR - Argentina 3
RO - Romania 3
AU - Australia 2
FR - Francia 2
TR - Turchia 2
A1 - Anonimo 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
EE - Estonia 1
NZ - Nuova Zelanda 1
ZA - Sudafrica 1
Totale 1.728
Città #
Fairfield 215
Seattle 88
Ashburn 80
Rome 76
Chandler 75
Houston 75
Cambridge 72
Woodbridge 72
Wilmington 65
Singapore 61
San Paolo di Civitate 37
Santa Clara 35
Ann Arbor 25
Princeton 25
San Diego 24
Lawrence 23
Beijing 22
Lomé 18
Dublin 16
Millbury 14
Fremont 13
Plano 13
Helsinki 11
Sofia 11
Boston 10
Dearborn 10
Jakarta 10
Milan 10
Moscow 10
New York 10
Cagliari 9
Andover 7
Des Moines 7
Toronto 7
Hong Kong 6
Messina 5
Phoenix 5
Bloomfield Hills 4
Bremen 4
Bühl 4
Caldogno 4
Norwalk 4
Bologna 3
Federal 3
Hyderabad 3
Ottawa 3
Redwood City 3
Assèmini 2
Berlin 2
Boardman 2
Buffalo 2
Florence 2
Gallarate 2
Guastameroli 2
Istanbul 2
Lamézia 2
Medford 2
Nanjing 2
Philadelphia 2
Pune 2
Vibo Valentia 2
Yuncheng 2
Zhengzhou 2
Arienzo 1
Auckland 1
Baku 1
Brentford 1
Büdelsdorf 1
Castelnuovo Di Porto 1
Catania 1
Chatsworth 1
Chieti 1
Dallas 1
Dhaka 1
Falls Church 1
Fasano 1
Formia 1
Frankfurt am Main 1
Groningen 1
Guangzhou 1
Kelvin Grove 1
Kunming 1
Latina 1
Leawood 1
London 1
Mehr 1
Montréal 1
Muizenberg 1
New Delhi 1
Oxford 1
Poplar 1
Rotterdam 1
San Jose 1
Santiago 1
Scottsdale 1
Shanghai 1
Shaoxing 1
Southwark 1
Tallinn 1
Venezia 1
Totale 1.376
Nome #
Rimegepant. calcitonin gene-related peptide (CGRP) receptor antagonist, treatment of migraine 123
Xanthurenic Acid Activates mGlu2/3 metabotropic glutamate receptors and is a potential trait marker for schizophrenia 122
Altered kynurenine pathway metabolites in serum of chronic migraine patients 98
Changes in serum levels of kynurenine metabolites in paediatric patients affected by ADHD 97
Choosing the safest acute therapy during chronic migraine prophylactic treatment. pharmacokinetic and pharmacodynamic considerations 93
Pharmacogenetic considerations for migraine therapies 92
Precise medical decision making in geriatric anti-depressant therapy 87
Changing the approach to anticoagulant therapy in older patients with multimorbidity using a precision medicine approach 87
Acute, transitional and long-term cluster headache treatment. pharmacokinetic issues 86
Eletriptan in the management of acute migraine. An update on the evidence for efficacy, safety, and consistent response 83
LC-MS/MS simultaneous analysis of allopregnanolone; epiallopregnanolone; pregnanolone; dehydroepiandrosterone and dehydroepiandrosterone 3-sulfate in human plasma 83
How do you choose the appropriate migraine pharmacotherapy for an elderly person? 82
Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing–Remitting Multiple Sclerosis Treated With Dimethylfumarate 76
Migraine and cluster headache show impaired neurosteroids patterns 74
O066. Kynurenine pathway metabolites in cluster headache 73
Profiling lasmiditan as a treatment option for migraine 70
Polyamines serum levels in episodic and chronic migraine 58
Atogepant. Calcitonin gene-related peptide (CGRP) receptor antagonist, Preventive treatment of migraine 57
Urinary and exhaled biomarkers of exercise-induced bronchoconstriction in atopic asthmatic children 50
Persistent post-traumatic headache and migraine: Pre-clinical comparisons 50
Fremanezumab for the preventive treatment of migraine in adults 49
Ubrogepant for the treatment of migraine 49
null 48
Cgrp receptor antagonists and 5-ht1f receptor agonist in the treatment of migraine 32
Kinurenine pathway in children with Attention Deficit-Hyperactivity Disorder (ADHD) 31
Psychotropic Drugs Levels in Seminal Fluid: A New Therapeutic Drug Monitoring Analysis? 12
Totale 1.862
Categoria #
all - tutte 5.294
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.294


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020294 0 0 0 0 0 48 52 49 55 35 42 13
2020/2021174 27 5 16 12 9 19 0 5 17 36 13 15
2021/2022323 21 27 33 14 33 25 6 29 16 21 56 42
2022/2023323 51 91 16 31 37 25 7 23 18 5 13 6
2023/2024157 9 20 8 13 10 25 2 18 4 12 17 19
2024/2025169 4 39 14 24 41 47 0 0 0 0 0 0
Totale 1.862